Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the
IBD therapy
atherosclerotic cardiovascular disease
inflammatory bowel disease
ischemic heart disease
ischemic stroke
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2023
2023
Historique:
received:
12
01
2023
accepted:
04
05
2023
medline:
1
6
2023
pubmed:
1
6
2023
entrez:
1
6
2023
Statut:
epublish
Résumé
Atherosclerotic cardiovascular disease and stroke are the leading causes of morbidity and mortality worldwide. Along to the traditional risk factors for these diseases, chronic inflammation is known to be an important player in accelerating the process of atherosclerosis, which can result in an increased incidence of arterial thromboembolic events. As in other chronic inflammatory diseases, in the past few years, several studies suggested that subjects affected by inflammatory bowel diseases (IBD) may also be at an incremented risk of atherosclerotic disease, especially during the periods of disease's flare. Therefore, IBD treatment may assume an important role for achieving both disease remission and the control of the atherosclerotic risk. In this article we aimed to perform a comprehensive review on evidence on the increased risk of arterial thromboembolic events in patients affected by IBD and discuss the potential role of IBD therapy in reducing this risk.
Identifiants
pubmed: 37260950
doi: 10.3389/fcvm.2023.1143293
pmc: PMC10227624
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1143293Informations de copyright
© 2023 Gabbiadini, Dal Buono, Mastrorocco, Solitano, Repici, Spinelli, Condorelli and Armuzzi.
Déclaration de conflit d'intérêts
AA has received consulting and/or advisory board fees from AbbVie, Allergan, Amgen, Arena, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celltrion, Eli-Lilly, Ferring, Galapagos, Gilead, Janssen, MSD, Mylan, Pfizer, Protagonist Therapeutics, Roche, Samsung Bioepis, Sandoz, and Takeda; lecture and/or speaker bureau fees from AbbVie, Amgen, Arena, Biogen, Bristol-Myers Squibb, Celltrion, Eli-Lilly, Ferring, Galapagos, Gilead, Janssen, MSD, Mitsubishi Tanabe, Novartis, Pfizer, Roche, Samsung Bioepis, Sandoz, Takeda, and Tigenix; and research grants from MSD, Pfizer, Takeda and Biogen. AS has served as a speaker, consultant or advisory board member for Ethicon, Takeda, Pfizer, Sofar, and Oasis. AR received a consultancy fee from Medtronic. RG has received speaker fees from Pfizer. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Scand J Gastroenterol. 1998 May;33(5):504-8
pubmed: 9648990
J Immunol Res. 2019 Dec 1;2019:7247238
pubmed: 31886308
Clin Exp Gastroenterol. 2020 Apr 24;13:107-113
pubmed: 32425576
PLoS One. 2018 Aug 31;13(8):e0201991
pubmed: 30169521
Gut. 1995 May;36(5):724-30
pubmed: 7541009
Coron Artery Dis. 2021 Jan;32(1):73-77
pubmed: 32310848
Neurology. 2021 Nov 16;97(20 Suppl 2):S6-S16
pubmed: 34785599
J Crohns Colitis. 2011 Feb;5(1):41-7
pubmed: 21272803
J Clin Lipidol. 2017 Sep - Oct;11(5):1243-1256
pubmed: 28751001
Biomed Res Int. 2014;2014:312647
pubmed: 24587984
Int J Colorectal Dis. 2015 May;30(5):645-53
pubmed: 25608496
Inflamm Bowel Dis. 2021 Apr 15;27(5):629-638
pubmed: 32618340
N Engl J Med. 2004 Dec 16;351(25):2599-610
pubmed: 15602020
Inflamm Bowel Dis. 2020 Jan 1;26(1):43-55
pubmed: 31211831
Clin Gastroenterol Hepatol. 2020 Jan;18(1):123-132.e3
pubmed: 31077827
Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):205-17
pubmed: 25732745
Europace. 2014 Apr;16(4):477-84
pubmed: 24108228
Brain Behav. 2021 Jun;11(6):e02159
pubmed: 33960728
Lancet Gastroenterol Hepatol. 2019 Aug;4(8):643-654
pubmed: 31171484
Clin Gastroenterol Hepatol. 2018 Oct;16(10):1607-1615.e1
pubmed: 29702298
Am J Gastroenterol. 2011 Apr;106(4):741-7
pubmed: 21386828
Nature. 2001 May 31;411(6837):603-6
pubmed: 11385577
J Korean Med Sci. 2022 Apr 25;37(16):e123
pubmed: 35470598
Lancet. 2017 Apr 29;389(10080):1756-1770
pubmed: 27914657
Exp Ther Med. 2017 Feb;13(2):395-400
pubmed: 28352306
Lancet. 2021 Jun 19;397(10292):2372-2384
pubmed: 34090625
Gastroenterology. 2021 Oct;161(4):1118-1132
pubmed: 34358489
Arch Dermatol Res. 2017 Apr;309(3):225-228
pubmed: 28213804
J Am Coll Cardiol. 2020 Dec 15;76(24):2895-2905
pubmed: 33303079
PLoS One. 2013;8(2):e56944
pubmed: 23457642
Inflamm Bowel Dis. 2021 Jun 15;27(7):1107-1115
pubmed: 32978937
Transl Stroke Res. 2017 Feb;8(1):3-13
pubmed: 26987852
J Am Coll Cardiol. 2009 Oct 20;54(17):1561-75
pubmed: 19833255
Diabetes Care. 2007 Apr;30(4):939-45
pubmed: 17392554
N Engl J Med. 2022 Jan 27;386(4):316-326
pubmed: 35081280
Z Gastroenterol. 2021 Feb;59(2):117-124
pubmed: 33233007
Expert Rev Clin Immunol. 2023 Apr;19(4):375-391
pubmed: 36722283
Lancet. 2022 Jun 4;399(10341):2113-2128
pubmed: 35644166
N Engl J Med. 2017 May 4;376(18):1723-1736
pubmed: 28467869
J Stroke Cerebrovasc Dis. 2015 Dec;24(12):2774-80
pubmed: 26360973
J Clin Lab Anal. 2022 Oct;36(10):e24685
pubmed: 36045604
Clin Rev Allergy Immunol. 2018 Dec;55(3):254-270
pubmed: 28741263
Front Pharmacol. 2022 Feb 02;12:837509
pubmed: 35185553
Nat Rev Cardiol. 2023 Jan;20(1):24-37
pubmed: 35840742
BMC Med. 2014 Mar 18;12:47
pubmed: 24642015
Clin Gastroenterol Hepatol. 2023 Jan;21(1):164-172.e11
pubmed: 35842123
Eur J Intern Med. 2020 May;75:10-14
pubmed: 32151491
Eur J Intern Med. 2014 Jul;25(6):561-5
pubmed: 24906568
Ann Intern Med. 2006 Jul 4;145(1):21-9
pubmed: 16818925
Gastroenterology. 2020 May;158(6):1554-1573.e12
pubmed: 31926171
Nature. 2001 May 31;411(6837):599-603
pubmed: 11385576
Front Immunol. 2022 Apr 14;13:860703
pubmed: 35493452
Eur J Prev Cardiol. 2018 Oct;25(15):1623-1631
pubmed: 30074405
Inflamm Bowel Dis. 2014 Sep;20(9):1593-601
pubmed: 25105946
Clin Gastroenterol Hepatol. 2008 Jan;6(1):41-5
pubmed: 18063423
Aliment Pharmacol Ther. 2019 Oct;50(7):769-779
pubmed: 31396984
Clin Gastroenterol Hepatol. 2023 Mar;21(3):761-770.e13
pubmed: 36075499
Inflamm Bowel Dis. 2023 Apr 3;29(4):531-538
pubmed: 35590447
Adv Ther. 2022 Jan;39(1):738-753
pubmed: 34877631
Circulation. 2019 Sep 10;140(11):e563-e595
pubmed: 30879339
Front Cell Infect Microbiol. 2022 Oct 04;12:1015890
pubmed: 36268225
Clin Exp Gastroenterol. 2020 May 04;13:123-129
pubmed: 32440189
Inflamm Bowel Dis. 2019 May 4;25(6):1080-1087
pubmed: 30500938
Cardiol Rev. 2018 Nov/Dec;26(6):287-293
pubmed: 30277903
Lancet. 2010 Jan 9;375(9709):132-40
pubmed: 20031199
N Engl J Med. 2017 Oct 19;377(16):1537-1550
pubmed: 29045212
Inflamm Bowel Dis. 2010 Aug;16(8):1387-92
pubmed: 20014016
Hum Immunol. 2011 Aug;72(8):636-40
pubmed: 21565239
Clin Pharmacol Ther. 2008 Jan;83(1):70-6
pubmed: 17507924
J Am Heart Assoc. 2017 Aug 2;6(8):
pubmed: 28768646
Aliment Pharmacol Ther. 2000 Sep;14(9):1169-79
pubmed: 10971234
JAMA Netw Open. 2022 Sep 1;5(9):e2234200
pubmed: 36178685
Inflamm Bowel Dis. 2014 Mar;20(3):502-7
pubmed: 24412991
Med Sci Monit. 2015 Aug 07;21:2305-15
pubmed: 26252649
Therap Adv Gastroenterol. 2021 Jul 28;14:17562848211032126
pubmed: 34377149
Gut. 2020 May;69(5):852-858
pubmed: 31446428
Pharmacol Ther. 2010 Sep;127(3):295-314
pubmed: 20621692
Semin Arthritis Rheum. 2016 Dec;46(3):261-271
pubmed: 27443588
Indian J Gastroenterol. 2014 Mar;33(2):151-6
pubmed: 24222372
Int J Cardiol. 2016 Jan 1;202:106-9
pubmed: 26386936
Eur Heart J Open. 2021 Oct 14;2(1):oeab029
pubmed: 35919661
Aliment Pharmacol Ther. 2022 Feb;55(4):464-478
pubmed: 34854095
Lancet. 2017 Apr 29;389(10080):1741-1755
pubmed: 27914655
Gut. 2014 Aug;63(8):1275-83
pubmed: 24021287
Clin Gastroenterol Hepatol. 2011 Oct;9(10):875-80
pubmed: 21749853
Inflamm Bowel Dis. 2022 Jun 2;28(Supple 2):S52-S58
pubmed: 34969082
J Crohns Colitis. 2020 Feb 10;14(2):192-204
pubmed: 31504340
Aliment Pharmacol Ther. 2006 Sep;24 Suppl 1:2-9
pubmed: 16939423
Inflamm Bowel Dis. 2016 Sep;22(9):2229-37
pubmed: 27542135
Ann N Y Acad Sci. 2010 Oct;1207 Suppl 1:E86-93
pubmed: 20961311
Gut. 2018 Jul;67(7):1261-1268
pubmed: 28647686
Am J Gastroenterol. 2018 Mar;113(3):405-417
pubmed: 29336432
Dig Dis Sci. 2022 Nov;67(11):5206-5212
pubmed: 35113275
J Crohns Colitis. 2019 Mar 26;13(3):319-323
pubmed: 30321330
Int J Mol Med. 2006 Jun;17(6):997-1004
pubmed: 16685407
Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):857-873
pubmed: 34453143
Inflamm Bowel Dis. 2021 May 17;27(6):797-808
pubmed: 32870265
Pharmacol Res. 2020 Aug;158:104835
pubmed: 32416212
Nat Commun. 2017 Oct 10;8(1):845
pubmed: 29018189
J Crohns Colitis. 2019 Apr 26;13(5):541-554
pubmed: 30445584
Am J Prev Cardiol. 2022 Jan 17;9:100316
pubmed: 35112094
Angiology. 2021 Apr;72(4):303-314
pubmed: 33601945
Eur J Gastroenterol Hepatol. 1999 Feb;11(2):175-9
pubmed: 10102229
Gut. 2013 May;62(5):689-94
pubmed: 22961677
Immunol Invest. 2019 Jul;48(5):505-520
pubmed: 30961407
Arthritis Care Res (Hoboken). 2019 Oct;71(10):1387-1395
pubmed: 31112005
J Crohns Colitis. 2022 Aug 30;16(8):1222-1234
pubmed: 35239968
Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2364-7
pubmed: 10521365
Inflamm Bowel Dis. 2012 Jun;18(6):1048-56
pubmed: 21826766
N Engl J Med. 2012 Aug 16;367(7):616-24
pubmed: 22894574
J Stroke Cerebrovasc Dis. 2021 Jul;30(7):105787
pubmed: 33865232
Aliment Pharmacol Ther. 2020 Dec;52(11-12):1658-1675
pubmed: 33086438